Alan Yu

Director, Division of Nephrology and Hypertension and The Kidney Institute · University of Kansas School of Medicine

Credentials: · · · · · ·

History

Division of Nephrology and Hypertension and The Kidney Institute · University of Kansas School of Medicine
Present
Kansas Institute for Precision Medicine COBRE Center · University of Kansas School of Medicine
Present
University of Kansas School of Medicine
Present

Claudins and the modulation of tight junction permeability
Review · Physiological Reviews · 2013 · 1,150 citations
Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden
Journal of the American Society of Nephrology · 2016 · Last of 12 authors · 371 citations
Biology of claudins
Review · American Journal of Physiology-Renal Physiology · 2008 · Last of 3 authors · 283 citations

Role of Claudin-2 in Calcium Homeostasis and Kidney Stone Disease
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $2.5M · University of Kansas Medical Center
2019–2031
Kansas PKD Research and Translation Core Center
National Institute of Diabetes and Digestive and Kidney Diseases · U54
PI · $1.7M · University of Kansas Medical Center
2020–2030
The Kansas Institute for Precision Medicine
National Institute of General Medical Sciences · P20
PI · $18.9M · University of Kansas Medical Center
2019–2029
Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) IV: Prognosis for End-Stage Renal Disease and Biomarker Validation
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $3.5M · University of Kansas Medical Center
2017–2023

Early PKD Observational Cohort Study
Principal investigator · Recruiting
University of Kansas Medical Center
2016–2031
Pilot Study of Niacinamide in Polycystic Kidney Disease (NIAC-PKD2)
Principal investigator · Completed · Phase 2
University of Kansas Medical Center
2015–2017
Uncontrolled, Open Label, Pilot and Feasibility Study of Niacinamide in Polycystic Kidney Disease
Principal investigator · Completed · Phase 2
Alan Yu, MB, BChir
2014